{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T18:22:49Z","timestamp":1775672569758,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21fk0108621"],"award-info":[{"award-number":["JP21fk0108621"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22wm0325044"],"award-info":[{"award-number":["JP22wm0325044"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K15667"],"award-info":[{"award-number":["JP21K15667"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22KJ2672"],"award-info":[{"award-number":["JP22KJ2672"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23H02952"],"award-info":[{"award-number":["JP23H02952"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"JST","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009023","name":"Precursory Research for Embryonic Science and Technology","doi-asserted-by":"publisher","award":["JPMJPR21R7"],"award-info":[{"award-number":["JPMJPR21R7"]}],"id":[{"id":"10.13039\/501100009023","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jiac.2023.09.016","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T02:26:17Z","timestamp":1694831177000},"page":"159-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparing minimum inhibitory concentrations of amikacin for pulmonary Mycobacterium avium complex disease: An analysis of culture media differences"],"prefix":"10.1016","volume":"30","author":[{"given":"Atsuho","family":"Morita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6181-4284","authenticated-orcid":false,"given":"Ho","family":"Namkoong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Uwamino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2288-077X","authenticated-orcid":false,"given":"Satoshi","family":"Mitarai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Aono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9752-9589","authenticated-orcid":false,"given":"Kazuma","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5299-3978","authenticated-orcid":false,"given":"Hiromu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Azekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Nakagawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genta","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2023.09.016_bib1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries","volume":"185","author":"Adjemian","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2023.09.016_bib2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3201\/eid2206.151086","article-title":"Epidemiology of pulmonary nontuberculous mycobacterial disease","volume":"22","author":"Namkoong","year":"2016","journal-title":"Japan. Emerg Infect Dis."},{"key":"10.1016\/j.jiac.2023.09.016_bib3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1186\/s12879-017-2665-5","article-title":"The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases","volume":"17","author":"Yagi","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2023.09.016_bib4","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.2147\/IDR.S373783","article-title":"Early-phase adverse effects and management of liposomal amikacin inhalation for refractory Mycobacterium avium complex lung disease in real-world settings","volume":"15","author":"Morita","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jiac.2023.09.016_bib5","series-title":"Susceptibility testing of mycobacteria, nocardia spp., and other aerobic actinomycetes","year":"2018"},{"key":"10.1016\/j.jiac.2023.09.016_bib6","series-title":"Performance standards for susceptibility testing of mycobacteria, nocardia spp., and other aerobic actinomycetes","year":"2018"},{"key":"10.1016\/j.jiac.2023.09.016_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2023.09.016_bib8","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1164\/rccm.201807-1318OC","article-title":"Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT). A prospective, open-label, randomized study","volume":"198","author":"Griffith","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2023.09.016_bib9","series-title":"Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes","year":"2003"},{"key":"10.1016\/j.jiac.2023.09.016_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fmicb.2020.00081","article-title":"Rational choice of antibiotics and media for Mycobacterium avium complex drug susceptibility testing","volume":"11","author":"Jaffr\u00e9","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiac.2023.09.016_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1128\/JCM.00750-06","article-title":"Detection of multidrug resistance in Mycobacterium tuberculosis","volume":"45","author":"Sekiguchi","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2023.09.016_bib12","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1038\/s41598-021-85721-5","article-title":"Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2023.09.016_bib13","doi-asserted-by":"crossref","first-page":"O297","DOI":"10.1111\/1469-0691.12405","article-title":"In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex","volume":"20","author":"Lavollay","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2023.09.016_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00155-17","article-title":"Rifabutin is active against Mycobacterium abscessus complex","volume":"61","author":"Aziz","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.09.016_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.diagmicrobio.2018.06.015","article-title":"The stability of antimycobacterial drugs in media used for drug susceptibility testing","volume":"92","author":"Schoutrop","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.jiac.2023.09.016_bib16","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2217\/fmb.14.60","article-title":"Drug susceptibility testing of nontuberculous mycobacteria","volume":"9","author":"van Ingen","year":"2014","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jiac.2023.09.016_bib17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1128\/JCM.41.2.627-631.2003","article-title":"Multisite reproducibility of results obtained by two broth dilution methods for susceptibility testing of Mycobacterium avium complex","volume":"41","author":"Woods","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2023.09.016_bib18","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1128\/JCM.01612-13","article-title":"In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates","volume":"51","author":"Brown-Elliott","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2023.09.016_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12866-022-02582-2","article-title":"In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates","volume":"22","author":"Lin","year":"2022","journal-title":"BMC Microbiol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2300226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2300226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:06:46Z","timestamp":1761160006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X2300226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1341321X2300226X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2023.09.016","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing minimum inhibitory concentrations of amikacin for pulmonary Mycobacterium avium complex disease: An analysis of culture media differences","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2023.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}